---
title: "Zynex (ZYXI.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ZYXI.US.md"
symbol: "ZYXI.US"
name: "Zynex"
industry: "Health Care Equipment"
datetime: "2026-04-15T06:49:27.193Z"
locales:
  - [en](https://longbridge.com/en/quote/ZYXI.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ZYXI.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ZYXI.US.md)
---

# Zynex (ZYXI.US)

## Company Overview

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; and M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body; and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, braces for rehabilitation support for knee and wrist, and Dynacomp for cold compression therapy.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-04-15T04:30:17.000Z

**Overall: D (0.64)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 169 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -44.13% |  |
| Net Profit YoY | -1633.13% |  |
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 0.00 |  |
| Revenue | 108202000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 2641.83% | A |
| Profit Margin | -68.35% | E |
| Gross Margin | 61.19% | A |
| Revenue YoY | -44.13% | E |
| Net Profit YoY | -1633.13% | E |
| Total Assets YoY | -64.05% | E |
| Net Assets YoY | -215.65% | E |
| Cash Flow Margin | -146.30% | E |
| OCF YoY | -44.13% | E |
| Turnover | 1.26 | A |
| Gearing Ratio | 191.28% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Zynex",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-44.13%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-1633.13%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.00",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "0.00",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "108202000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "2641.83%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-68.35%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "61.19%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-44.13%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-1633.13%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-64.05%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-215.65%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-146.30%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-44.13%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "1.26",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "191.28%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.08 | 49/183 | 24.33 | 22.67 | 22.01 |
| PB | -0.14 | 147/183 | 35.80 | 13.65 | 3.19 |
| PS (TTM) | 0.05 | 7/183 | 0.38 | 0.30 | 0.05 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Abbott Laboratories (ABT.US) | B | C | C | C | B | B |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | B | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | B | B | C | C | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ZYXI.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ZYXI.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ZYXI.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ZYXI.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**